General Mills is cashing in on probiotics

December 11, 2018 | Case Study

One of our key predictions at the start of 2018 was increased investment and acquisition activity around probiotics (and prebiotics). This prediction has come to life throughout the year, with General Mills' venture arm (301 Inc.) being particularly active. Of the 10 companies within its portfolio, five sell products containing probiotics. Of those five, three received investments in 2018, all led by 301 Inc.: NextFoods ($12 million round, $40 million to date), Kite Hill ($40 million round, $65 million to date), and Urban Remedy ($17 million round, $23 million to date). The other two companies with probiotic-containing products that have previously received investments from 301 Inc. are Farmhouse Culture and Good Culture.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978